Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Jun;64(6):798–800. doi: 10.1136/ard.2005.039248

The needle and the damage done*

J Franz 1, G Burmester 1
PMCID: PMC1755515  PMID: 15897300

Full Text

The Full Text of this article is available as a PDF (61.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amano Y., Lee S. W., Allison A. C. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Mol Pharmacol. 1993 Feb;43(2):176–182. [PubMed] [Google Scholar]
  2. Bondeson J. The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen Pharmacol. 1997 Aug;29(2):127–150. doi: 10.1016/s0306-3623(96)00419-3. [DOI] [PubMed] [Google Scholar]
  3. Burmester G. R., Locher P., Koch B., Winchester R. J., Dimitriu-Bona A., Kalden J. R., Mohr W. The tissue architecture of synovial membranes in inflammatory and non-inflammatory joint diseases. I. The localization of the major synovial cell populations as detected by monoclonal reagents directed towards Ia and monocyte-macrophage antigens. Rheumatol Int. 1983;3(4):173–181. doi: 10.1007/BF00541597. [DOI] [PubMed] [Google Scholar]
  4. Burmester G. R., Stuhlmüller B., Keyszer G., Kinne R. W. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum. 1997 Jan;40(1):5–18. doi: 10.1002/art.1780400104. [DOI] [PubMed] [Google Scholar]
  5. Catrina Anca Irinel, Trollmo Christina, af Klint Erik, Engstrom Marianne, Lampa Jon, Hermansson Ylva, Klareskog Lars, Ulfgren Ann Kristin. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum. 2005 Jan;52(1):61–72. doi: 10.1002/art.20764. [DOI] [PubMed] [Google Scholar]
  6. Cronstein Bruce N. Therapeutic cocktails for rheumatoid arthritis: the mixmaster's guide. Arthritis Rheum. 2004 Jul;50(7):2041–2043. doi: 10.1002/art.20374. [DOI] [PubMed] [Google Scholar]
  7. Cunnane G., Madigan A., Murphy E., FitzGerald O., Bresnihan B. The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis. Rheumatology (Oxford) 2001 Jan;40(1):62–69. doi: 10.1093/rheumatology/40.1.62. [DOI] [PubMed] [Google Scholar]
  8. Cutolo M., Sulli A., Ghiorzo P., Pizzorni C., Craviotto C., Villaggio B. Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. Ann Rheum Dis. 2003 Apr;62(4):297–302. doi: 10.1136/ard.62.4.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dolhain R. J., Tak P. P., Dijkmans B. A., De Kuiper P., Breedveld F. C., Miltenburg A. M. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br J Rheumatol. 1998 May;37(5):502–508. doi: 10.1093/rheumatology/37.5.502. [DOI] [PubMed] [Google Scholar]
  10. Firestein Gary S. Evolving concepts of rheumatoid arthritis. Nature. 2003 May 15;423(6937):356–361. doi: 10.1038/nature01661. [DOI] [PubMed] [Google Scholar]
  11. Gerlag Danielle M., Haringman Jasper J., Smeets Tom J. M., Zwinderman A. H., Kraan Maarten C., Laud Peter J., Morgan Shethah, Nash Anthony F. P., Tak Paul P. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum. 2004 Dec;50(12):3783–3791. doi: 10.1002/art.20664. [DOI] [PubMed] [Google Scholar]
  12. Grell M., Douni E., Wajant H., Löhden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 1995 Dec 1;83(5):793–802. doi: 10.1016/0092-8674(95)90192-2. [DOI] [PubMed] [Google Scholar]
  13. Haringman J. J., Gerlag D. M., Zwinderman A. H., Smeets T. J. M., Kraan M. C., Baeten D., McInnes I. B., Bresnihan B., Tak P. P. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2004 Dec 2;64(6):834–838. doi: 10.1136/ard.2004.029751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Haringman J. J., Kraan M. C., Smeets T. J. M., Zwinderman K. H., Tak P. P. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis. Ann Rheum Dis. 2003 Aug;62(8):715–721. doi: 10.1136/ard.62.8.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hayman Alison R., Cox Timothy M. Tartrate-resistant acid phosphatase: a potential target for therapeutic gold. Cell Biochem Funct. 2004 Sep-Oct;22(5):275–280. doi: 10.1002/cbf.1133. [DOI] [PubMed] [Google Scholar]
  16. Kinne R. W., Bräuer R., Stuhlmüller B., Palombo-Kinne E., Burmester G. R. Macrophages in rheumatoid arthritis. Arthritis Res. 2000 Apr 12;2(3):189–202. doi: 10.1186/ar86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kobayashi Yukinao, Ueyama Seiichi, Arai Yoshinori, Yoshida Yasushi, Kaneda Toshio, Sato Takuya, Shin Kitetsu, Kumegawa Masayoshi, Hakeda Yoshiyuki. The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage. J Bone Miner Metab. 2004;22(4):318–328. doi: 10.1007/s00774-003-0489-4. [DOI] [PubMed] [Google Scholar]
  18. Kraan M. C., Reece R. J., Barg E. C., Smeets T. J., Farnell J., Rosenburg R., Veale D. J., Breedveld F. C., Emery P., Tak P. P. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers. Arthritis Rheum. 2000 Aug;43(8):1820–1830. doi: 10.1002/1529-0131(200008)43:8<1820::AID-ANR18>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  19. Kraan M. C., Versendaal H., Jonker M., Bresnihan B., Post W. J., t Hart B. A., Breedveld F. C., Tak P. P. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 1998 Aug;41(8):1481–1488. doi: 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  20. Loetscher P., Dewald B., Baggiolini M., Seitz M. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine. 1994 Mar;6(2):162–170. doi: 10.1016/1043-4666(94)90038-8. [DOI] [PubMed] [Google Scholar]
  21. Mulherin D., Fitzgerald O., Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996 Jan;39(1):115–124. doi: 10.1002/art.1780390116. [DOI] [PubMed] [Google Scholar]
  22. Nakamura H., Igarashi M. Localization of gold in synovial membrane of rheumatoid arthritis treated with sodium aurothiomalate. Studies by electron microscope and electron probe x-ray microanalysis. Ann Rheum Dis. 1977 Jun;36(3):209–215. doi: 10.1136/ard.36.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pap T., Müller-Ladner U., Gay R. E., Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000 Jun 8;2(5):361–367. doi: 10.1186/ar113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pettit A. R., Weedon H., Ahern M., Zehntner S., Frazer I. H., Slavotinek J., Au V., Smith M. D., Thomas R. Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritis. Rheumatology (Oxford) 2001 Nov;40(11):1243–1255. doi: 10.1093/rheumatology/40.11.1243. [DOI] [PubMed] [Google Scholar]
  25. Rhodes Laura A., Tan Ai Lyn, Tanner Steven F., Radjenovic Aleksandra, Hensor Elizabeth M. A., Reece Richard, O'Connor Philip, Emery Paul, McGonagle Dennis. Regional variation and differential response to therapy for knee synovitis adjacent to the cartilage-pannus junction and suprapatellar pouch in inflammatory arthritis: implications for pathogenesis and treatment. Arthritis Rheum. 2004 Aug;50(8):2428–2432. doi: 10.1002/art.20444. [DOI] [PubMed] [Google Scholar]
  26. Seitz M., Loetscher P., Dewald B., Towbin H., Rordorf C., Gallati H., Baggiolini M., Gerber N. J. Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol. 1995 Jul;34(7):602–609. doi: 10.1093/rheumatology/34.7.602. [DOI] [PubMed] [Google Scholar]
  27. Singh Jasvinder A., Pando Jose A., Tomaszewski John, Schumacher H. Ralph. Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid-naïve patients. J Rheumatol. 2004 Jul;31(7):1281–1285. [PubMed] [Google Scholar]
  28. Smeets Tom J. M., Kraan Maarten C., van Loon Marieke E., Tak Paul-Peter. Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum. 2003 Aug;48(8):2155–2162. doi: 10.1002/art.11098. [DOI] [PubMed] [Google Scholar]
  29. Stuhlmüller B., Ungethüm U., Scholze S., Martinez L., Backhaus M., Kraetsch H. G., Kinne R. W., Burmester G. R. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. Arthritis Rheum. 2000 Apr;43(4):775–790. doi: 10.1002/1529-0131(200004)43:4<775::AID-ANR8>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  30. Urushibara Makoto, Takayanagi Hiroshi, Koga Takako, Kim Sunhwa, Isobe Miho, Morishita Yasuyuki, Nakagawa Takumi, Löeffler Monika, Kodama Tatsuhiko, Kurosawa Hisashi. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1. Arthritis Rheum. 2004 Mar;50(3):794–804. doi: 10.1002/art.20206. [DOI] [PubMed] [Google Scholar]
  31. Verhoef C. M., van Roon J. A., Vianen M. E., Lafeber F. P., Bijlsma J. W. The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production. Ann Rheum Dis. 1999 Jan;58(1):49–54. doi: 10.1136/ard.58.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yanni G., Nabil M., Farahat M. R., Poston R. N., Panayi G. S. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis. 1994 May;53(5):315–322. doi: 10.1136/ard.53.5.315. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES